Project Grant K99HL186065
Award Date 6/5/26
Completion Date 5/31/28
Dollars Obligated $166K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94304, USA
Similar Awards
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a $2.44 million Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) on August 15, 2025, with a completion date of July 31, 2030. This five-year award supports research to identify causal gene programs that influence vascular diseases, specifically coronary artery disease and pulmonary arterial hypertension. The project will deliver advanced...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a $770,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) effective April 1, 2026, with a completion date of January 31, 2033. This research grant funds an integrated, multimodal investigation into endothelial-cardiomyocyte crosstalk mechanisms in cardiomyopathy. The project will deliver fundamental scientific research utilizing human...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a $410,449 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) beginning August 1, 2025, with a completion date of July 31, 2027. This grant supports the development of novel synthetic biology strategies to enhance cell-based therapies for peripheral arterial disease (PAD), a condition affecting over 8 million Americans. The research will...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a Project Grant of $761,017.00 under the Cardiovascular Diseases Research program (CFDA 93.837) for the period of September 1, 2025, through June 30, 2029. This research initiative, titled "Human Pulmonary Neuroendocrine Progenitors in Lung Injury and Disease," focuses on advancing scientific understanding of pulmonary neuroendocrine cells (PNECs) and their...
- Federal Project Grant Award Summary The Leland Stanford Junior University received a $165,888 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded April 15, 2026, with a completion date of March 31, 2031. The award funds research investigating the role of T cell contributions to neointima formation in pulmonary hypertension (PH), a fatal disease characterized by abnormal cell proliferation that...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a Project Grant of $262,170 under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through May 31, 2027. This K99/R00 research training award supports a five-year investigative plan led by Dr. Arianne Caudal to elucidate the cardiac-protective mechanisms of sodium-glucose cotransporter-2 inhibitors (SGLT2i) through advanced molecular...
- Federal Project Grant Award Summary The Leland Stanford Junior University received a $2.34 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded May 1, 2026, with completion targeted for January 31, 2028. The award funds research investigating the role of phospholamban (PLN) in regulating perinuclear calcium signaling within cardiomyocytes and its implications for pathological cardiac remodeling....
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Leland Stanford Junior University a $166,968 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on September 15, 2025, with completion targeted for June 30, 2030. This research initiative delivers a community-engaged intervention study designed to reduce ultra-processed food (UPF) consumption in preschool children, specifically toddlers aged 2–3 years, to improve cardiovascular health...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Project Grant of $160,818 to The Leland Stanford Junior University, effective August 1, 2025 through July 31, 2027, under the Cardiovascular Diseases Research program (CFDA 93.837). This research project aims to identify druggable genetic factors underlying radiation-induced heart disease (RIHD) by establishing a cell village comprising 96 human induced pluripotent stem cell (iPSC) lines derived...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Stanford University a Project Grant of $159,512 under the Cardiovascular Diseases Research program (CFDA 93.837) effective December 1, 2025, with completion targeted for May 1, 2026. This grant supports research into amelioration of cardiac fibrosis using diverse cell village human cardiac organoids. The project focuses on developing and validating therapeutic approaches to combat fibroblast activation, a...